Dapsone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00250 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 31 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pneumocystosis | KG + DL |
| 2 | malaria | KG + DL |
| 3 | familial acanthosis nigricans | KG + DL |
| 4 | urticaria, familial localized heat | KG + DL |
| 5 | van den Bosch syndrome | KG + DL |
| 6 | Tietz syndrome | KG + DL |
| 7 | aplasia cutis-myopia syndrome | KG + DL |
| 8 | familial pityriasis rubra pilaris | KG + DL |
| 9 | pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa | KG + DL |
| 10 | anhidrosis, familial generalized, with abnormal or absent sweat glands | KG + DL |
| 11 | alkaptonuria | KG + DL |
| 12 | X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome | KG + DL |
| 13 | erythrokeratodermia-cardiomyopathy syndrome | KG + DL |
| 14 | inherited cutis laxa | KG + DL |
| 15 | familial primary localized cutaneous amyloidosis | KG + DL |
| 16 | keratosis follicularis-dwarfism-cerebral atrophy syndrome | KG + DL |
| 17 | deafness, congenital, with total albinism | KG + DL |
| 18 | Buschke-Ollendorff syndrome | KG + DL |
| 19 | dyschromatosis universalis hereditaria | KG + DL |
| 20 | deaf blind hypopigmentation syndrome, Yemenite type | KG + DL |
| 21 | nail infection | KG + DL |
| 22 | seborrheic keratosis | KG + DL |
| 23 | syndromic oculocutaneous albinism | KG + DL |
| 24 | vulvar inverted follicular keratosis | KG + DL |
| 25 | poikiloderma with neutropenia | KG + DL |
| 26 | punctate epithelial keratoconjunctivitis | KG + DL |
| 27 | demodicidosis of sebaceous gland | KG + DL |
| 28 | paronychia (disease) | KG + DL |
| 29 | isolated congenital adermatoglyphia | KG + DL |
| 30 | exposure keratitis | KG + DL |
| 31 | heparin-induced thrombocytopenia (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.